U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07054398) titled 'Assessment of Serum Catestatin Level in Acne Vulgaris Patients' on May 15.
Brief Summary: Acne vulgaris is a persistent inflammatory condition of the pilosebaceous unit, affecting 85% of people between the ages of 12 and 24, it is regarded as one of the most common diseases in teenagers and young adults.
Catestatin, a peptide derived from chromogranin A (CgA), was first discovered in 1997 as an acute nicotinic-cholinergic antagonist. Later, it was determined that CST is a pleiotropic hormone.
Study Start Date: Jan. 10
Study Type: INTERVENTIONAL
Condition:
Acne Vulgaris
Intervention:
DRUG: Isotretinoin
* Measure the serum leve...